Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye

NCT02581891 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)
DRUG: Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer

Collaborators

[object Object]